Management Team

Dr. Cooper has enjoyed a long and successful career in both academia and the pharmaceutical industry.
From 1971-1995, Dr. Cooper served in various academic appointments including Professor and Associate Dean at Georgetown University, University of Medicine and Dentistry of New Jersey, University of Pennsylvania and Temple University.
From 1995-2005, he served as a Senior Vice President of Clinical and Medical Affairs at Wyeth Consumer Healthcare, where he designed the clinical development plans for Advil Liquigels, Advil Allergy and Sinus and Advil PM.
He also holds patents for various analgesic combination products. He currently is a Board member of the Eastern Pain Association.
Dr. Cooper is most well-known as the developer of the Dental Impaction Pain Model, one of the most widely used pain models in the world. He has published in peer reviewed journals over 100 clinical papers on a wide variety of analgesic drugs.

Mr. Kasan has over 40 years of experience in pharmaceutical formulation and process development, 37 of these with Teva Pharmaceutical Industries Ltd.
Mr. Kasan was responsible for the management and development of over 200 approved products in North America , the EU and Israel .
In his last position at Teva, Mr. Kasan was Corporate Vice President, Pharmaceutical Chief Technology Officer.
Other positions at Teva included:

• Vice President for Global R&D ( Generic ) Integration
• Deputy Head of the Global R&D Division
• Director of Generic Pharmaceutical R&D

Mr.Kasan is the recipient of the prestigious Rothschild Prize for Innovation/Export granted for the development of Copaxone for the treatment of multiple sclerosis .